Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

Abbott Laboratories (ABT_KZ)

KASE
Currency in USD
104.50
0.00(0.00%)
Closed

ABT_KZ Income Statement

Advanced Income Statement
Period Ending:
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa31,90434,60843,07543,65340,109
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+4.34%+8.48%+24.47%+1.34%-8.12%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa13,23115,00318,08019,08317,919
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa18,67319,60524,99524,57022,190
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+4.42%+4.99%+27.49%-1.7%-9.69%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa58.53%56.65%58.03%56.28%55.32%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa13,91614,14315,79115,45714,970
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-0.91%+1.63%+11.65%-2.12%-3.15%
aa.aaaa.aaaa.aaaa.aaaa.aa2,4402,4202,7382,7412,619
aa.aaaa.aaaa.aaaa.aaaa.aa9,5409,59111,00610,70310,385
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa4,7575,4629,2049,1137,220
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+23.94%+14.82%+68.51%-0.99%-20.77%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa14.91%15.78%21.37%20.88%18%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-576-500-490-375-252
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+20.11%+13.19%+2%+23.47%+32.8%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-670-546-533-558-637
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa944643183385
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-41216-42-63
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa4,1404,9838,7208,6966,905
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-63100--111-58
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa4,0774,9688,2118,3066,664
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+41.91%+21.85%+65.28%+1.16%-19.77%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa12.78%14.36%19.06%19.03%16.61%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa3904971,1401,373941
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa3,6874,4957,0716,9335,723
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa3,6874,4957,0716,9335,723
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+55.7%+21.91%+57.31%-1.95%-17.45%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa11.56%12.99%16.42%15.88%14.27%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa2122292822
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa3,6664,4497,0426,9055,701
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa2.072.513.973.943.28
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+57.19%+21.02%+58.1%-0.71%-16.82%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa2.062.493.943.913.26
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+57.25%+20.87%+58.23%-0.76%-16.62%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa1,7681,7731,7751,7531,740
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa1,7811,7861,7891,7641,749
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa1.321.531.821.922.08
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+13.79%+15.91%+18.95%+5.49%+8.33%
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa7,7718,78912,74212,38010,463
EBITDA Growth
aa.aaaa.aa